Skip To Main Content
Michael Cammarata on Muck Rack

Michael Cammarata

United States
As seen in: Medium, Entrepreneur, Green Entrepreneur, The Rheumatologist
Covers:  Entrepreneurship, Sustainability, Wellness, Investment
Entrepreneur & Investor | CEO @Neptune_Corp: (@SproutFoods, Biodroga Nutraceuticals, @ForestRemedies ) | @Unilever: (@SchmidtsNatural, Alex AI) | #SproutLove

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Michael Cammarata’s Biography

Read Full Bio →

Michael Cammarata is the President and CEO of Neptune Wellness Solutions, a company whose purpose is to transform the everyday for a healthier tomorrow. In 2015, Micheal invested in and co-founded Schmidt’s Naturals, one of the fastest growing wellness brands, taking it from fledgling start-up to acquisition by Unilever in 2017. With Michael at the helm, the company reached record breaking growth, rapidly expanding into new and innovative products, retailers, and global markets.

Where you can f…

Michael Cammarata’s Journalist Portfolio

New Strategies to Cope With Your Supply Chain and Pandemic-Related Disruptions

New Strategies to Cope With Your Supply Chain and Pandemic-Related Disruptions

It has become my personal mission to both grow brands and become a force for good in this world. For other co…

View article →
The Future & Vision for Neptune Wellness

The Future & Vision for Neptune Wellness

Over the last two years, our forward-thinking team has been busy transforming Neptune Wellness, a pioneer in …

View article →
Consumers Demand a Stance on Social and Political Issues. Are You Ready to Speak Out?

Consumers Demand a Stance on Social and Political Issues. Are You Ready to Speak Out?

Opinions expressed by Entrepreneur contributors are their own. Consumer activism is nothing new. Americans ha…

View article →
The Companies That Serve Society Will Thrive

The Companies That Serve Society Will Thrive

When it comes to purchasing decisions, consumers want to be viewed as individuals. There's a reason why 63% o…

View article →
How Personalization Is Transforming the Consumer Goods Marketplace

How Personalization Is Transforming the Consumer Goods Marketplace

Uniformity used to be what attracted the mass market. Think of Henry Ford's astonishing production line - row…

View article →
What I Learned After One of the World's Leading Brands Acquired My Startup

What I Learned After One of the World's Leading Brands Acquired My Startup

Opinions expressed by Entrepreneur contributors are their own. As the CEO of a public company, your job is tw…

View article →

Articles

A Case-Based Approach to Managing Myositis

|
By Michael Cammarata
| The Rheumatologist Verified
CHICAGO—Immune-mediated inflammatory myopathies represent a heterogenous group of diseases with variable degrees of multisystem involvement, including the skin, joints, lungs, and muscles. The ACR Convergence 2025 session, Management of Challenging Cases in Myositis, featured a case-based approach to highlight this complexity, guiding attendees through the nuances of diagnosis and management of antisynthetase syndrome, immune-mediated necrotizing myopathy and dermatomyositis.
Open in Who Shared Issue with article?

The Great Pediatric Debate—Corticosteroids in SLE: Slay or Stay? - The Rheumatologist

|
By Michael Cammarata
| The Rheumatologist Verified
CHICAGO—Corticosteroids have been an essential tool for the treatment of SLE since the 1950s. However, long-term use is associated with numerous adverse effects, particularly in children, and guidance is lacking on how to manage low-dose prednisone in clinically quiescent disease. In The Great Debate at ACR Convergence 2025—Corticosteroids in Pediatric SLE: Slay or Stay, two pediatric lupus experts took to the stage to explore this important topic.
Open in Who Shared Issue with article?

The Great Debate: Ultrasound vs. Temporal Artery Biopsy in Giant Cell Arteritis

|
By Michael Cammarata
| The Rheumatologist Verified
CHICAGO—Temporal artery biopsy (TAB) has long been the gold standard for the diagnosis of giant cell arteritis (GCA). However, with continued advancements in ultrasound resolution and growing provider expertise, temporal artery ultrasound (TAUS) is increasingly being used in practice.
Open in Who Shared Issue with article?
See all 18 articles

Awards

See all →

Portland Business Journal Executive of the Year

2017 - Business

The Portland Business Journal honors a selection of 10 of the region's biggest movers and shakers, whose strategies and philosophies led to the very best performances of 2017.

Entrepreneur 360™ Entrepreneur Magazine

2017 - Innovation and Leadership

The Entrepreneur 360™ Award recognizes companies and founders for their impact, innovation, growth, and leadership.

Entrepreneur of the Year Pacific Northwest Ernst & Young

2017 - Most Dynamic Entrepreneurs

The Ernst & Young Entrepreneur of the Year Awards honors the most dynamic entrepreneurs forging a better future.